Cardiac Dyssynchrony in Congestive Heart Failure and Atrial Fibrillation. Integrating Regularization and Resynchronization

Journal of the American College of Cardiology

Volumn 52, Issue 15, 2008, Pages 1247-1249

  Bartunek, Jozef ^a   Vanderheyden, Marc ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

atrial fibrillation; atrioventricular junction ablation; cardiac dyssynchrony; cardiac resynchronization therapy; heart failure

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; CONGESTIVE HEART FAILURE; EDITORIAL; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MITRAL VALVE REGURGITATION; MORTALITY; PRIORITY JOURNAL; QRS COMPLEX; SINUS RHYTHM; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HUMANS;

EID: 52949115361     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.07.018     Document Type: Editorial

References (23)

1. Rivero-Ayerza M., Theuns D.A.M.J., Garcia-Garcia H.M., Boersma E., Simoons M., and Jordaens L.J. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized clinical trials. Eur Heart J 27 (2006) 2682-2688
2. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J 28 (2007) 2256-2295
3. Upadhyay G.A., Choudhry N.K., Auricchio A., Ruskin J., and Singh J.P. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol 52 (2008) 1239-1246
4. Linde C., Leclerq C., Rex S., et al., MUltisite Stimulation in Cardiomyopathies (MUSTIC) Study Group. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite Stimulation in Cardiomyopathies (MUSTIC) study. J Am Coll Cardiol 40 (2002) 111-118
5. Khadjooi K., Foley P.W., Chalil S., et al. Long-term effects of cardiac resynchronization therapy in patients with atrial fibrillation. Heart 94 (2008) 879-883
6. Gasparini M., Auricchio A., Metra M., et al. Long-term survival in patients undergoing cardiac resynchronization therapy: importance of atri-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 29 (2008) 1644-1652
7. Bleeker G.B., Mollema S.A., and Holman E.R. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy. Analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation 116 (2007) 1440-1448
8. Delnoy P.P.H.M., Otervanger J.P., Luttikhuis H.O., et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 99 (2007) 1252-1257
9. Gasparini M., Auricchio A., Regoli F., et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression. The importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48 (2006) 734-743
10. Melenevsky V., Hay I., and Fetics B.J. Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy. Eur Heart J 26 (2005) 705-711
11. Doshi R.N., Daoud E.G., Fellows C., et al. Left ventricular-based cardiac stimulation Post AV Nodal Ablation Evaluation (the PAVE study). J Cardiovasc Electrophysiol 16 (2005) 1160-1165
12. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
13. Geelen P., Brugada J., Andries E., and Brugada P. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 20 (1997) 343-348
14. Chen M.S., Marrouche N.F., Khyakin Y., et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 43 (2004) 1004-1008
15. Hsu L.F., Jais P., Sanders P., et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351 (2004) 2373-2383
16. Calkins H., Brugada J., Packer D.L., et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow up. A report of the Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 4 (2007) 816-861
17. Chung E.S., Leon A.R., Tavazzi L., et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117 (2008) 2608-2616
18. Penicka M., Bartunek J., De Bruyne B., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
19. Vanderheyden M., De Backer T., Rivero-Ayerza M., et al. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy. Heart Rhythm 24 (2005) 1066-1072
20. Van Gelder B.M., Meijer A., and Bracke F.A. Stimulation rate and the optimal interventricular interval during cardiac resynchronization therapy in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 31 (2008) 569-574
21. Maisel W.H., and Warner S. Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy. Am J Cardiol 91 Suppl (2003) 2D-8D
22. Vanderheyden M., Mullens W., Delrue L., et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy: responders versus nonresponders. J Am Coll Cardiol 51 (2008) 129-136
23. Iyengar S., Haas G., Lamba S., et al. Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy. J Card Fail 13 (2007) 304-311